Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Following our announcement on 18 November 2008, requests have now been sent to MA holders for products containing gemcitabine where product information has not already been updated. Further information is available on our Medicines for children pages.
›
Medicines for children
›
MHRA exercise to update Summaries of Product Characteristics (SmPCs) to include paediatric information following completion of European work-sharing procedures
